|
| |
In general, the risk of malignancy is not increased
in patients with multinodular goitre, but in the
few cases where malignancy is suspected (e.g.
prominent firm to hard cold nodule with nondiagnostic
or neoplastic cells by fine needle aspiration,
rapidly growing nodule, a vocal cord
paralysis, suspicious lymph nodes in the neck,
past neck irradiation) surgery is the option. In the
vast majority of patients where malignancy is not
suspected assesment of thyroid function is important
for choice of treatment. A high normal or elevated
serum TSH suggest an autoimmune component
of the goitre, and that TSH stimulation is
involved in goitrogenesis. T4 substitution therapy
to achieve low normal serum TSH is recommended.
Reference ranges for serum TSH normally
include subjects with borderline subclinical
autoimmune thyroiditis and serum TSH tends to
decrease in multinodular goitre. Hence, serum
TSH above 2 mU/l (depending on assay) is high
for a patient with goitre.
|
|